Myrbetriq
Myrbetriq

2.01
Used to address bladder and urinary conditions, this generic medicine relaxes the bladder muscle to increase storage capacity and reduce urgency symptoms.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Mirabegron
Reference Brand
Mirabegron
Product Origin
Generic Alternative
Reference Manufacturer
Astellas Pharma
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Beta-3 Adrenergic Agonist
Pharmacological Class
Urinary Antispasmodic
Clinical Indications
Manufacturer Description
Developed to mitigate bladder detrusor muscle hyperactivity to support bladder holding capacity and alleviate urgency.
Mechanism of Action
Selectively stimulates beta-3 adrenergic receptors, relaxing the detrusor muscle during the bladder storage phase.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Severe uncontrolled hypertension, End-stage renal disease
Severe Adverse Events
Angioedema — requires immediate medical attention, Severe hypertensive crisis — requires immediate medical attention
Common Side Effects
Headache, Nasopharyngitis, Nausea
Uncommon Side Effects
Elevated blood pressure, Urinary tract infection, Tachycardia
Drug Interactions
Metoprolol, Digoxin
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits justify risks. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for children over three years and adults based on formulation.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Myrbetriq is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to buy Cholesterol Tablets - Buy Cholestyramine AU